Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NRL |
| Upstream (Parents) |
|---|
| (<<) SALL1 → NRL |
| (<<) ASCL2 → NRL |
| (<<) CDX2 → NRL |
| (<<) ZNF80 → NRL |
| (<<) HOPX → NRL |
| (<<) GCM1 → NRL |
| (<<) FOXO3 → NRL |
| (<<) POU3F4 → NRL |
| (<<) PPARD → NRL |
| (<<) DLX4 → NRL |
| (<<) PHOX2A → NRL |
| (<<) BACH2 → NRL |
| (<<) AFF1 → NRL |
| (<<) JUN → NRL |
| (<<) CEBPA → NRL |
| (<<) PURA → NRL |
| (<<) RFX3 → NRL |
| Downstream (Children) |
|---|
| NRL → ZBTB17 (>>) |
| NRL → TBX10 (>>) |
